Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yangzheng Compound Mixture is a traditional Chinese medicine oral liquid manufactured by Shaanxi Buchang Pharmaceutical. It is a compound formulation containing extracts from multiple herbs, including Red Ginseng (Ginseng Rubra Radix), Astragali Radix, Lycii Fructus, Ligustri Lucidi Fructus, Polyporus Umbellatus, and Poria. [1, 9] Primarily used as an adjuvant therapy for cancer patients, particularly those undergoing chemotherapy, it addresses symptoms associated with Qi-Yin deficiency, such as fatigue, and helps manage side effects like leukopenia (low white blood cell count). [2, 4] Scientific studies suggest that the mixture possesses immunomodulatory and anti-tumor properties. [6, 8] In-vitro research has shown that its components can inhibit cancer cell proliferation, arrest the cell cycle, and impair cell migration. [8] A nationwide clinical study has also been conducted to evaluate its effects on sleep disorders in cancer patients. [1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yangzheng Compound Mixture.